Canadian Online Pharmacy

CDRH Transparency Update

You are subscribed to CDRH Transparency for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

The following PMAs were recently added to Premarket Approval (PMA) Summary Review Memos for 180-Day Design Changes .

 

  • P060027/S032
  • P980049/S065
  • P960042/S031
  • P030005/S079
  • P970003/S132
  • P890003/S214
  • P980016/S280
  • P950037/S100
  • P000009/S047
  • P050023/S048
  • P070008/S028
  • P880006/S075
  • P880086/S211
  • P910023/S279
  • P970013/S044
  • P030035/S089
  • P030054/S206
  • P950037/S084

CDRH Transparency home page


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery